Alterity Therapeutics (ATHE) Presents Positive Phase 2 Data for ATH434
Alterity Therapeutics Limited (NASDAQ:ATHE) is one of the best performing ASX stocks in 2025.
Alterity Therapeutics Limited (ATHE)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 16,811 | $51,778 | -25% | 0% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 139,258 | $428,915 | 0.19% | |
| 2. | 63,682 | $196,140 | 0% | |
| 3. | 58,460 | $180,057 | 0% | |
| 4. | 32,000 | $98,560 | 0% | |
| 5. | 6,909 | $21,280 | 0% |
News See All
10 Best Performing ASX Stocks in 2025
Australian equities have delivered strong returns in 2025. The S&P/ASX 200 Index is up 7.15% year-to-date, and about 20% above the April 7 slump.
Alterity Therapeutics Limited (ATHE) Announces Positive Topline Data From Phase 2 Trial of ATH434 in Multiple System Atrophy
Alterity Therapeutics Limited (NASDAQ:ATHE) is among the 12 Best Australian Stocks to Buy Right Now.
12 Best Australian Stocks to Buy Right Now
Australia’s S&P/ASX 200 index advanced 0.53% on Thursday to close at 8,873.80, with investors buoyed by gains in the banking sector, amid robust earnings and renewed hopes for further interest rate ...
11 Best Australian Stocks to Buy According to Analysts
The tariffs announced by the United States have challenged the economic and market outlooks around the globe.
10 Best Australian Stocks to Buy According to Billionaires
In December 2024, Ausbil Investment Management Limited released its equity market outlook 2025.
10 Best ASX Stocks to Buy According to Hedge Funds
According to a report by the Australian Bureau of Statistics (ABS) published on December 4, 2024, the Australian economy grew by 0.3% in the September quarter of 2024, which marked the twelfth consecutive...
Hedge Fund Resource Center